Israel Englander Johnson & Johnson Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Johnson & Johnson stock. As of the latest transaction made, Millennium Management LLC holds 689,200 shares of JNJ stock, worth $108 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

689,200

Previous 696,500 1.05%

Holding current value

$108 Million

Previous $110 Million 8.57%

% of portfolio

0.05%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $128 Million - $140 Million	-885,145 Reduced 45.11%	1,076,973 $157 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $275 Million - $288 Million	1,770,538 Added 924.18%	1,962,118 $310 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $226 Million - $247 Million	-1,551,617 Reduced 89.01%	191,580 $30 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $138 Million - $149 Million	896,341 Added 105.84%	1,743,197 $289 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $71.3 Million - $85.1 Million	472,024 Added 125.93%	846,856 $131 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $83.5 Million - $93.7 Million	-521,381 Reduced 58.18%	374,832 $66.2 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $113 Million - $126 Million	701,574 Added 360.45%	896,213 $146 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $29.6 Million - $32.8 Million	176,283 Added 960.36%	194,639 $34.6 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $34.5 Million - $39.2 Million	-218,313 Reduced 92.24%	18,356 $3.25 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $16.7 Million - $18.6 Million	107,266 Added 82.89%	236,669 $40.5 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $196 Million - $217 Million	-1,211,177 Reduced 90.35%	129,403 $20.9 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $147 Million - $158 Million	921,641 Added 219.99%	1,340,580 $221 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $189 Million - $211 Million	-1,237,603 Reduced 74.71%	418,939 $68.9 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $211 Million - $242 Million	1,539,427 Added 1314.46%	1,656,542 $261 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $106 Million - $116 Million	-757,039 Reduced 86.6%	117,115 $17.4 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $66 Million - $79.7 Million	512,211 Added 141.52%	874,154 $123 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $83.2 Million - $115 Million	-748,541 Reduced 67.41%	361,943 $47.5 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $54.9 Million - $63.1 Million	430,885 Added 63.4%	1,110,484 $162 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $59.6 Million - $66.7 Million	469,545 Added 223.54%	679,599 $87.9 Million
Q2 2019 Aug 15, 2019	SELL	$131.15 - $144.24 $72.7 Million - $79.9 Million	-554,044 Reduced 72.51%	210,054 $29.3 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $26 Million - $28.6 Million	198,526 Added 35.1%	764,098 $37.1 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $2.69 Million - $3 Million	21,436 Added 3.94%	565,572 $79.1 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $122 Million - $147 Million	-995,099 Reduced 64.65%	544,136 $70.2 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $51 Million - $59.9 Million	-419,072 Reduced 21.4%	1,539,235 $213 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $123 Million - $136 Million	1,032,162 Added 111.45%	1,958,307 $238 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $10.5 Million - $12.4 Million	-83,767 Reduced 8.29%	926,145 $119 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $75.5 Million - $82.6 Million	575,038 Added 132.23%	1,009,912 $141 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $56.3 Million - $58.9 Million	434,874	434,874 $56.5 Million

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account